AmerisourceBergen Corporation (NYSE:ABC) Files An 8-K Regulation FD DisclosureItem 7.01. Regulation FD Disclosure.
AmerisourceBergen Corporation (NYSE:ABC) Files An 8-K Regulation FD Disclosure
On May 1, 2017, AmerisourceBergen Corporation (the “Company”) issued a news release announcing that the Company has signed a new five-year agreement to supply pharmaceuticals to Express Scripts Holding Company. A copy of the news release is attached to this Current Report as Exhibit 99.1.
The information contained in this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 News Release, dated May 1, 2017, of AmerisourceBergen Corporation.
About AmerisourceBergen Corporation (NYSE:ABC)
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment’s operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens. AmerisourceBergen Corporation (NYSE:ABC) Recent Trading Information
AmerisourceBergen Corporation (NYSE:ABC) closed its last trading session up +0.07 at 82.12 with 1,477,044 shares trading hands.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment’s operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens. AmerisourceBergen Corporation (NYSE:ABC) Recent Trading Information
AmerisourceBergen Corporation (NYSE:ABC) closed its last trading session up +0.07 at 82.12 with 1,477,044 shares trading hands.